[HTML][HTML] PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

MP Edlind, AC Hsieh - Asian journal of andrology, 2014 - journals.lww.com
Prostate cancer (PCa) is the second most common malignancy among men in the world.
Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which …

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance.

MP Edlind, AC Hsieh - Asian Journal of Andrology, 2014 - europepmc.org
Prostate cancer (PCa) is the second most common malignancy among men in the world.
Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which …

[引用][C] PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

AC Hsieh, MP Edlind - Asian Journal of Andrology, 2014 - cir.nii.ac.jp
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy
resistance | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

M Edlind, A Hsieh - Asian Journal of Andrology, 2014 - go.gale.com
Prostate cancer (PCa) is the second most common malignancy among men in the world.
Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which …

[HTML][HTML] PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

MP Edlind, AC Hsieh - Asian Journal of Andrology, 2014 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is the second most common malignancy among men in the world.
Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which …

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

MP Edlind, AC Hsieh - Asian journal of andrology, 2014 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is the second most common malignancy among men in the world.
Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which …

[PDF][PDF] PI3K‑AKT‑mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

MP Edlind, AC Hsieh - Asian Journal of Andrology, 2014 - Citeseer
An important mechanism that promotes castration resistance is persistent androgen receptor
(AR) signaling. 7-10 A number of contributing mechanisms involving genetic alterations to …

PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance.

MP Edlind, AC Hsieh - Asian Journal of Andrology, 2014 - search.ebscohost.com
Prostate cancer (PCa) is the second most common malignancy among men in the world.
Castration-resistant prostate cancer (CRPC) is the lethal form of the disease, which …

[PDF][PDF] PI3K‑AKT‑mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

MP Edlind, AC Hsieh - Asian Journal of Andrology, 2014 - scienceopen.com
An important mechanism that promotes castration resistance is persistent androgen receptor
(AR) signaling. 7-10 A number of contributing mechanisms involving genetic alterations to …

[PDF][PDF] PI3K‑AKT‑mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance

MP Edlind, AC Hsieh - Asian Journal of Andrology, 2014 - pdfs.semanticscholar.org
An important mechanism that promotes castration resistance is persistent androgen receptor
(AR) signaling. 7-10 A number of contributing mechanisms involving genetic alterations to …